SIPCAN
  • SIPCAN
    • Über SIPCAN
    • Ziele
    • Vorstand & Beirat
    • Team
    • Spenden
    • Institutionelle Partner
    • Industrielle Partner
    • Kontakt
  • Aktuell
  • Betriebe
    • Herz-Kreislauf-Check
    • Körper-Check
    • Fitness-Check
    • Ernährungs-Check
    • Vorträge
  • Schulen
    • Trink- und Jausenführerschein
    • Bewegung macht Spaß
    • Schlau Trinken
  • Verpflegung
    • Automaten
    • Schulbuffet
    • Menü Check
  • Checklisten
    • Getränkeliste
    • Milchliste
    • Süßigkeitenliste
    • Online Checklisten
    • Zucker-Challenge
  • Forschung
  • Downloads
    • Schulen
    • Checklisten
    • Betriebe
    • Leitfäden
    • Sonstiges
  • Gesundheitssituation Oesterreicher
  • Gesundheitssituation Kinder
  • Was Praevention bringt
  • Begriffe
  • Menü
  • Spenden
  • Aktuell neue Idee
  • Neue Seite
  • Downloads
  • Körper-Check
  • Schlau Informiert

Wissenschaftliche Papers - Archiv


In PubMed gelistet:

  • Kruschitz R, Wallner-Liebmann SJ, Lothaller H, Luger M, Schindler K, Hoppichler F, Ludvik B. Evaluation of a meal replacement-based weight management program in primary care settings according to the actual European Clinical Practice Guidelines for the Management of Obesity in Adults. Wiener klinische Wochenschrift. 2014;126:598-603.

  • T.E.Dorner, C. Lackinger, S. Haider, E. Luger, A. Kapan, M. Luger, K.E. Schindler: Nutrition intervention and physical training in malnourished, frail, community-dwelling, elderly subjects carried out by trained lay "buddies": Study protocol of a randomized controlled trial. BMC, 27.12.2013

  • R. Kruschitz, S.J. Wallner-Liebmann, M.J. Hamlin, B. Ludvik, W.J. Schnedl, E. Tafeit: Detecting Body Fat - A Weighty Problem BMI versus subcutaneous fat patterns. PLOS one, 26.08.2013

  • M. Luger, B. Holstein, K. Schindler, R. Kruschitz, B. Ludvik. Feasibility and Efficacy of an Isocaloric High-Protein vs. Standard Diet on Insulin Requirement, Body Weight and Metabolic Parameters in Patients with Type 2 Diabetes on Insulin Therapy. Experimental and Clinical Endocrinology & Diabetes, 14.05.2013

  • D. Weghuber, K. Miller, M. Meindl, G. Reeves, T. Postolache, S. Ring-Dimitriou, S. Dämon, J. Hattinger, M. Caroli, M. Neubauer, H. Mangge, E. Ardelt-Gattinger: Interdisciplinary score for the evaluation of bariatric treatment in obese children (BAREV-C). Int J Disabil Hum Dev 2012; Band 0, Heft 0, Seiten 1–7, ISSN (Online) 2191-0367, ISSN; (Print) 2191-1231, DOI: 10.1515/ijdhd-2012-0130, Dec 2012

  • K. Schindler, G. Vila, F. Hoppichler, M. Lechleitner, A. Luger, C. Anderwald, J. Höfler, G. Tomasec, A. Kautzky-Willer, B. Ludvik: The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome. Obesity Facts 2012, 5(2), 270-276 (The European Journal of Obesity).

  • Lechleitner M, Hoppichler F: Insulin therapy (Themenschwerpunkt: New treatment of diabetes mellitus). 
    Wien Med Wochenschr 2011, 161(11-12): 300-304. (published online May 23, 2011)

  • Dämon S, Schätzer M, Höfler J, Tomasec G, Hoppichler F: Nutrition and Diabetes mellitus: an overview of the current evidence (Themenschwerpunkt: New treatment of diabetes mellitus). Wien Med Wochenschr 2011, 161(11-12): 282-288. (published online April 4, 2011)

  • Schätzer M, Rust P, Elmadfa I: Fruit and vegetable intake in Austrian adults: intake frequency, serving sizes, reasons for and barriers to consumption, and potential for increasing consumption. Public Health Nutrition 2010, 13(4), 480-487 (Epub 2009 Okt 07).

  • Luef G, Rauchenzauner M, Waldmann M, Sturm W, Sandhofer A, Seppi K, Trinka E, Unterberger I, Ebenbichler CF, Joannidis M, Walser G, Bauer G, Hoppichler F, Lechleitner M: Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepiletic drug treatment.
    Epilepsy Res 2009, 86(1): 42-47 (Epub 2009 May 22).

  • Ludvik B, Brath H, Wascher T, Toplak H; Expertengruppe der Österr. Diabetes Gesellschaft (Ludvik B, Agneter E, Brath H, Fasching P, Francesconi C, Francesconi M, Hoppichler F, Lechleitner M, Luger A, Prager R, Schernthaner G, Toplak H, Wascher T, Weitgasser R): The significance of long acting insulin analogues in the treatment of type 2 diabetes mellitus (article in german). Wien Klin Wochenschr 121(13-14): 473-482.

  • Roden M, Huber K; HSP-Projektgruppe (Föger B, Felizeter M, Hilbe C, Wechselberger T, Wascher T, de Campo A, Eder M, Pressl MH, Sourij H, Brussee H, Ebenbichler C, Pachinger O, Biesenbach G, Nesser HJ, Steringer-Mascherbauer R, Sturmberger T, Hoppichler F, Höfler J, Maschke K, Paulweber B, Pichler M, Schörghuber M, Wimmer H, Roden M, Kacerovsky M, Lettner A, Podczeck-Schweighofer A, Prager R, Schernthaner G, Brix J, Slany J, Luger A, Handisurya A, Riedl M, Willfort-Ehringer A, Koppensteiner R, Huber K, Eber B, Mayr M, Tauss M): Lipid profiles and therapy status in the secondary prevention of high risk patients with cardiovascular disease and/or diabetes mellitus: the Austrian Hospital Screening Project (HSP) (article in german). Wien Klin Wochenschr 120(17-18): 558-565.

  • Rauchenzauner M, Haberlandt E, Scholl-Bürgi S, Ernst B, Hoppichler F, Karall D, Ebenbichler CF, Rostasy K, Luef G: Adiponectin and visfatin concentrations in children treated with valproic acid. Epilepsia 2008, 49(2): 353-357 (Epub 2007 Dec 6).

  • El-Khatib F, Rauchenzauner M, Lechleitner M, Hoppichler F, Naser A, Waldmann M, Trinka E, Unterberger I, Bauer G, Luef G: Valproate, weight gain and carbohydrate craving: A gender study. Seizure 2007, 16(3), 226-232.
Special Institute for Preventive Cardiology And Nutrition
Datenschutzinformation
Impressum